MRK
Merck & Company Inc
Merck & Company Inc historical holders
total: 18
Cullen Value Fund Merck & Company Inc transactions over time
- Total transactions:
- 9
- New positions:
- 1
- Reduced:
- 8
- Held since:
- 2019 Q3
- Held for:
- 27 quarters
- Latest activity:
- 2024 Q1
Jim Cullen has been an institutional investor in Merck & Company Inc (MRK) since 2019 Q3. According to 2026 Q1 report, Jim Cullen holds 5,697 shares with a market value of roughly $685.29K representing 2.41% of their equity portfolio. The fund/company first acquired MRK in 2019 Q3, initially purchasing 15,150 shares. Since the initial investment, Cullen Value Fund has made 8 more transactions in this position.
Does Jim Cullen still hold MRK?
Yes, Jim Cullen continues to hold Merck & Company Inc (MRK). According to their 2026 Q1 report, they maintain a position of 5,697 shares valued at approximately $685.29K, representing 2.41% of their equity portfolio.
When did Jim Cullen first invest in MRK?
Jim Cullen first invested in Merck & Company Inc (MRK) in 2019 Q3 at the reported quarter-end price of $84.18 per share, acquiring 15,150 shares in their initial purchase.
What is Jim Cullen's average cost basis for MRK?
Based on historical transaction data, Jim Cullen's estimated cost basis for Merck & Company Inc (MRK) is approximately $84.18 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $84.18
- Weighted AVG sell price:
- $98.90
MRK transactions history by Cullen Value Fund
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
3.24%
|
5,697
|
$131.95
|
$751,719
|
-8.20% (-509)
|
-0.3%
|
|
2023 Q4
|
3.05%
|
6,206
|
$109.02
|
$676,578
|
-13.89% (-1,001)
|
-0.52%
|
|
2023 Q3
|
3.56%
|
7,207
|
$102.95
|
$741,961
|
-5.31% (-404)
|
-0.19%
|
|
2023 Q2
|
3.95%
|
7,611
|
$115.39
|
$878,233
|
-7.08% (-580)
|
-0.3%
|
|
2023 Q1
|
3.95%
|
8,191
|
$106.39
|
$871,440
|
-19.92% (-2,037)
|
-0.91%
|
|
2022 Q3
|
4.23%
|
10,228
|
$86.12
|
$880,835
|
-9.40% (-1,061)
|
-0.4%
|
|
2021 Q2
|
3.40%
|
11,289
|
$77.77
|
$877,946
|
-5.77% (-691)
|
-0.2%
|
|
2019 Q4
|
3.63%
|
$90.95
|
-20.92% (-3,170)
|
|||
|
2019 Q3
|
3.28%
|
$84.18
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.